Cetirizine Hydrochloride Market

Market Overview

The Global Cetirizine Hydrochloride Market Size is projected to register a CAGR of approximately 3.4% during the forecast period 2023-2031.

Cetirizine hydrochloride is an antihistamine medication that decreases the body's natural chemical histamine. Histamine causes sneezing, watery eyes, and a runny nose. Cetirizine hydrochloride is a medication that is used to treat colds, allergies, itching, and swelling caused by hives. It is available with a prescription, although it is also available without a prescription in pharmacies and supermarkets. Compared to standard antihistamines, it does not cause drowsiness or anticholinergic adverse effects. Cetirizine comes in many forms, including conventional and chewable tablets, capsules, and solutions. Cetirizine hydrochloride treats hives-related colds, allergies, itching, and edema.

Market Dynamics

Market Drivers

• Increasing Allergic Disorder Prevalence

The increased prevalence of allergic disorders, such as seasonal allergies, allergic rhinitis, and urticaria, is a major driver of the Cetirizine Hydrochloride market. Allergies affect a substantial portion of the world's population, causing symptoms such as sneezing, itching, watery eyes, and nasal congestion. Cetirizine hydrochloride alleviates these symptoms by inhibiting histamine, a chemical generated during an allergic reaction. As the number of people suffering from allergies rises, so will the demand for treatments such as Cetirizine Hydrochloride.

• Growing Awareness and Accessibility

People are growing aware of allergy illnesses and the treatment choices available, including Cetirizine Hydrochloride. More people seek treatment for allergy symptoms as access to healthcare information and over-the-counter (OTC) drugs improves. Cetirizine Hydrochloride is commonly available without a prescription in pharmacies and retail stores, making it easy for anyone to get and use. Cetirizine Hydrochloride's wide availability and acknowledgment of its efficacy contribute to its market expansion.

Market Restraints

• Side Effects and Safety Concerns

The presence of potential side effects and safety concerns linked with the product is another limitation in the cetirizine hydrochloride. Although cetirizine hydrochloride is usually safe and well-tolerated, some people may develop side symptoms such as drowsiness, dry mouth, dizziness, or headache. Furthermore, particular populations, such as older people or those with specific medical conditions, may have a higher risk of unpleasant effects. These safety issues may impact cetirizine hydrochloride uptake and usage, limiting its market expansion.

Market Opportunities

• Over-the-Counter (OTC) Availability

Cetirizine hydrochloride is available in several countries as a prescription and over-the-counter (OTC) drug. Cetirizine hydrochloride's OTC availability has increased its accessibility to customers, allowing them to obtain the medication without a prescription. This simplicity of use has raised the demand for OTC cetirizine hydrochloride medicines. Companies in the market can seize this opportunity by advertising their over-the-counter cetirizine hydrochloride products, investing in marketing techniques, and developing distribution channels to reach a larger consumer base.

Market Scope

Segmental Analysis

Segment by Type

• Tablet

Cetirizine hydrochloride is an antihistamine medication. Cetirizine Hydrochloride, 10mg Tablets, are used to treat hayfever and other allergy diseases (e.g., sneezing, runny or itchy nose) as well as skin rashes (chronic nettle rash, idiopathic urticaria) in adults and children over the age of six.

• Solution

Cetirizine dihydrochloride oral solution is used to treat adults and children aged two years and older who have hay fever (seasonal allergic rhinitis), year-round allergies such as dust or pet allergies (perennial allergic rhinitis), and urticaria (swelling, redness, and itchiness of the skin).

Segment by Application

• Hospital

Cetirizine hydrochloride, a second-generation antihistamine, is widely used in hospitals for various indications. It is primarily used to treat allergic disorders such as hay fever, hives, and allergic rhinitis, reducing symptoms such as sneezing, itching, runny nose, and watery eyes. It is also widely used to treat allergic reactions to drugs and insect stings, offering comfort by preventing the action of histamine, a molecule that causes allergic reactions.

• Clinic

Cetirizine hydrochloride is a typical antihistamine drug used in clinical settings. Cetirizine relieves symptoms such as sneezing, itching, runny nose, and watery eyes by preventing the effect of histamine, a chemical generated during allergic responses. Because of its non-drowsy formulation and extended duration of action, cetirizine hydrochloride is frequently favored for acute and chronic allergy disorders.

• Drug Store

Cetirizine hydrochloride is an antihistamine medicine that is widely available in pharmacies. Cetirizine inhibits histamine, a chemical in the body that triggers allergic reactions. It has a non-drowsy recipe and is available in various formats to accommodate different age groups, including tablets, liquid, and chewable tablets. Cetirizine hydrochloride provides effective and consistent relief for allergy sufferers, allowing them to manage their symptoms and enhance their overall quality of life.

Regional Analysis

North America

North America is one of the most important target markets over the predicted period. The increased prevalence of hay fever and allergic conjunctivitis in countries like the United States has expanded the North American target market. Furthermore, the rising prevalence of allergic rhinitis has dramatically boosted the region's target market. Aside from that, an increase in the number of children with eczema has significantly influenced the growth of the target market in North America.

Europe

Cetirizine is available via prescription in Europe; however, it is also available in pharmacies and supermarkets. It comes in pill, capsule, and liquid form. Cetirizine Hydrochloride is a commonly used antihistamine in Europe and is marketed under various brand names, including Zyrtec, Reactine, and Cetrizine. It is frequently used to treat allergies caused by hay fever, dust mites, pet dander, and other allergens in the air. The European market for Cetirizine Hydrochloride is large, reflecting the region's allergy prevalence. The market is being pushed by factors such as increased allergy awareness and diagnosis, the availability of prescription and over-the-counter allergy relief treatments, and the growing need for effective medications.

Asia-Pacific

The Asia Pacific region has a big and diverse pharmaceutical market, with countries like China, India, Japan, South Korea, Australia, and others. These countries have a large population and a high prevalence of allergies, which creates a demand for treatments like Cetirizine Hydrochloride. The Asia Pacific market for Cetirizine Hydrochloride is projected to be influenced by population demographics, healthcare infrastructure, regulatory environment, and economic situations. Many Asian countries' growing middle-class populations, increasing urbanization, and changing lifestyles have increased allergy disorders, fuelling the demand for antihistamine drugs. Dr. Reddy's Laboratories, headquartered in Hyderabad, India, is one of the world's major Active Pharmaceutical Ingredients (API) manufacturers and suppliers of Cetirizine Dihydrochloride API.

South America

cetirizine Hydrochloride is an antihistamine drug that is often used to treat allergies. It comes in various forms, including tablets, syrups, and topical creams. Cetirizine Hydrochloride is available as a prescription medication and an over-the-counter (OTC) product in many countries, including South America.

Key Players

1. UCB Pharma
2. Pfizer
3. J & J
4. Mylan
5. Teva
6. HUAPONT Pharm
7. Hunan Jiudian Pharm
8. Sun Pharma
9. Lunan Pharma
10. Jubilant Life Sciences
11. Amneal
12. HAILING

Recent Developments

22 July 2022: Dr. Reddy's Laboratories has become the first to market with over-the-counter Fexofenadine and Pseudoephedrine Extended-Release pills in the United States. The launch of Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Extended Release Tablets to the upper respiratory portfolio of OTC drugs is important.